Merck (MRK) r&d spend was $15.8B in FY2025 (-12% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$15.8B
-12%
2024
$17.9B
-41%
2023
$30.5B
+125%
2022
$13.5B
+11%
2021
$12.2B
-9%
2020
$13.4B
+38%
2019
$9.7B
-0%
2018
$9.8B
-6%
2017
$10.3B
+1%
2016
$10.3B
+53%
2015
$6.7B
-7%
2014
$7.2B
-4%
2013
$7.5B
-8%
2012
$8.2B
-4%
2011
$8.5B
-24%
2010
$11.1B
+90%
2009
$5.8B
+22%
2008
$4.8B
-2%
2007
$4.9B
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q1 2026
$12.6B
Q4 2025
$3.9B
Q3 2025
$4.2B
Q2 2025
$4.0B
Q1 2025
$3.6B
Q4 2024
$4.6B
Q3 2024
$5.9B
Q2 2024
$3.5B
Q1 2024
$4.0B
Q4 2023
$9.6B
Q3 2023
$3.3B
Q2 2023
$13.3B
Source: MRK on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.